104 related articles for article (PubMed ID: 27623034)
1. Expression of HER2/Neu in B-Cell Acute Lymphoblastic Leukemia.
Rodriguez-Rodriguez S; Pomerantz A; Demichelis-Gomez R; Barrera-Lumbreras G; Barrales-Benitez O; Aguayo-Gonzalez A
Rev Invest Clin; 2016; 68(4):171-5. PubMed ID: 27623034
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of HER2/neu in acute lymphoblastic leukemia and induction of NK cell reactivity against primary ALL blasts by trastuzumab.
Haen SP; Schmiedel BJ; Rothfelder K; Schmied BJ; Dang TM; Mirza N; Möhle R; Kanz L; Vogel W; Salih HR
Oncotarget; 2016 Mar; 7(11):13013-30. PubMed ID: 26887048
[TBL] [Abstract][Full Text] [Related]
3. IKAROS Gene Deleted B-Cell Acute Lymphoblastic Leukemia in Mexican Mestizos: Observations in Seven Patients and a Short Review of the Literature.
Ruiz-Delgado GJ; Cantero-Fortiz Y; León-Peña AA; León-González M; Nuñez-Cortés AK; Ruiz-Argüelles GJ
Rev Invest Clin; 2016; 68(4):210-4. PubMed ID: 27623040
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic targets in childhood B-acute lymphoblastic leukemia: what about HER2/neu?
Camuset M; Huault A; Grain A; Clémenceau B; Rialland F; Thomas C; Chevallier P; Béné MC; Eveillard M
Hematol Oncol; 2021 Apr; 39(2):270-272. PubMed ID: 32894593
[No Abstract] [Full Text] [Related]
5. Overexpression of Her2/neu is observed in one third of adult acute lymphoblastic leukemia patients and is associated with chemoresistance in these patients.
Chevallier P; Robillard N; Wuilleme-Toumi S; Méchinaud F; Harousseau JL; Avet-Loiseau H
Haematologica; 2004 Nov; 89(11):1399-401. PubMed ID: 15531467
[TBL] [Abstract][Full Text] [Related]
6. Pediatric-Like Acute Lymphoblastic Leukemia Therapy in Adults With Lymphoblastic Lymphoma: The GRAALL-LYSA LL03 Study.
Lepretre S; Touzart A; Vermeulin T; Picquenot JM; Tanguy-Schmidt A; Salles G; Lamy T; Béné MC; Raffoux E; Huguet F; Chevallier P; Bologna S; Bouabdallah R; Benichou J; Brière J; Moreau A; Tallon-Simon V; Seris S; Graux C; Asnafi V; Ifrah N; Macintyre E; Dombret H
J Clin Oncol; 2016 Feb; 34(6):572-80. PubMed ID: 26644537
[TBL] [Abstract][Full Text] [Related]
7. Late recurrence of precursor B-cell acute lymphoblastic leukemia 9 years and 7 months after allogeneic hematopoietic stem cell transplantation.
Kato K; Kobayashi C; Kudo K; Hara T; Masuko K; Koike K; Tsuchida M
J Pediatr Hematol Oncol; 2010 Oct; 32(7):e290-3. PubMed ID: 20881873
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of multidrug resistance gene (MDR1) at relapse in a child with acute lymphoblastic leukemia.
Kourti M; Vavatsi N; Gombakis N; Tzimagiorgis G; Sidi V; Koliouskas D; Athanassiadou F
Pediatr Hematol Oncol; 2006 Sep; 23(6):489-94. PubMed ID: 16849280
[TBL] [Abstract][Full Text] [Related]
9. Incidence of thrombosis in adults with acute leukemia: a single center experience in Mexico.
Guzmán-Uribe P; Rosas-López A; Zepeda-León J; Crespo-Solís E
Rev Invest Clin; 2013; 65(2):130-40. PubMed ID: 23844531
[TBL] [Abstract][Full Text] [Related]
10. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
11. Trastuzumab clears HER2/neu-positive isolated tumor cells from bone marrow in primary breast cancer patients.
Rack B; Jückstock J; Günthner-Biller M; Andergassen U; Neugebauer J; Hepp P; Schoberth A; Mayr D; Zwingers T; Schindlbeck C; Friese K; Janni W
Arch Gynecol Obstet; 2012 Feb; 285(2):485-92. PubMed ID: 21717141
[TBL] [Abstract][Full Text] [Related]
12. [Her2-Neu expression in ductal adenocarcinomas of the breast gland: correlation with histopathological parameters and estrogen receptors' expression in Mexican patients].
Brück P; Vilches Cisneros N; Ramos López E; Barboza Quintana O; Ancer Rodríguez J; Flores Gutiérrez JP
Ginecol Obstet Mex; 2006 Oct; 74(10):516-22. PubMed ID: 21961357
[TBL] [Abstract][Full Text] [Related]
13. Minimal residual disease analysis by eight-color flow cytometry in relapsed childhood acute lymphoblastic leukemia.
Karawajew L; Dworzak M; Ratei R; Rhein P; Gaipa G; Buldini B; Basso G; Hrusak O; Ludwig WD; Henze G; Seeger K; von Stackelberg A; Mejstrikova E; Eckert C
Haematologica; 2015 Jul; 100(7):935-44. PubMed ID: 26001791
[TBL] [Abstract][Full Text] [Related]
14. Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity.
Stanton SE; Ward MM; Christos P; Sanford R; Lam C; Cobham MV; Donovan D; Scheff RJ; Cigler T; Moore A; Vahdat LT; Lane ME; Chuang E
BMC Cancer; 2015 Apr; 15():267. PubMed ID: 25885598
[TBL] [Abstract][Full Text] [Related]
15. BCL6 expression correlates with the t(1;19) translocation in B-lymphoblastic leukemia.
Deucher AM; Qi Z; Yu J; George TI; Etzell JE
Am J Clin Pathol; 2015 Apr; 143(4):547-57. PubMed ID: 25780007
[TBL] [Abstract][Full Text] [Related]
16. Lineage classification of childhood acute lymphoblastic leukemia according to the EGIL recommendations: results of the ALL-BFM 2000 trial.
Ratei R; Schabath R; Karawajew L; Zimmermann M; Möricke A; Schrappe M; Ludwig WD
Klin Padiatr; 2013 May; 225 Suppl 1():S34-9. PubMed ID: 23700065
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.
Brissot E; Labopin M; Beckers MM; Socié G; Rambaldi A; Volin L; Finke J; Lenhoff S; Kröger N; Ossenkoppele GJ; Craddock CF; Yakoub-Agha I; Gürman G; Russell NH; Aljurf M; Potter MN; Nagler A; Ottmann O; Cornelissen JJ; Esteve J; Mohty M
Haematologica; 2015 Mar; 100(3):392-9. PubMed ID: 25527562
[TBL] [Abstract][Full Text] [Related]
18. [Acute myeloid leukemia in adults: experience at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán from 2003 to 2008].
Buitrón-Santiago N; Arteaga-Ortiz L; Rosas-López A; Aguayo A; López-Karpovitch X; Crespo-Solís E
Rev Invest Clin; 2010; 62(2):100-8. PubMed ID: 20597388
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies.
Esteva FJ; Cheli CD; Fritsche H; Fornier M; Slamon D; Thiel RP; Luftner D; Ghani F
Breast Cancer Res; 2005; 7(4):R436-43. PubMed ID: 15987448
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
